Trials / Completed
CompletedNCT02496546
An Explorative Trial Evaluating the Effect of LEO 32731 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)
An Explorative Trial Evaluating the Effect of LEO 32731 Cream 20 mg/g in Adults With Mild to Moderate Atopic Dermatitis (AD)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- LEO Pharma · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this trial is to assess the efficacy of LEO 32731 cream 20 mg/g compared with LEO 32731 cream vehicle in adults with mild to moderate AD after 3 weeks of treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LEO 32731 cream | Applied for 3 weeks |
| DRUG | LEO 32731 cream vehicle | Applied for 3 weeks |
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2016-03-01
- Completion
- 2016-03-01
- First posted
- 2015-07-14
- Last updated
- 2017-05-03
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02496546. Inclusion in this directory is not an endorsement.